These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1439068)
1. [Determining factors of acceleration in sustained monomorphic ventricular tachycardias in response to bursts of stimuli]. San Román Sánchez D; Almendral Garrote J; Arenal Maíz A; Delcán Domínguez JL Rev Esp Cardiol; 1992; 45(7):438-46. PubMed ID: 1439068 [TBL] [Abstract][Full Text] [Related]
2. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms. Masotti CS; Pierangeli A Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709 [TBL] [Abstract][Full Text] [Related]
3. Spontaneous changes in ventricular tachycardia cycle length and their relation to earliest sites of epicardial activation in a canine model. Gómez MJ; Hélie F; Sierra G; Rocque P; Vinet A; Cardinal R; Nadeau R Arch Inst Cardiol Mex; 2000; 70(1):9-18. PubMed ID: 10855406 [TBL] [Abstract][Full Text] [Related]
4. Multiple monomorphic ventricular tachycardia configurations predict failure of antiarrhythmic drug therapy guided by electrophysiologic study. Mitrani RD; Biblo LA; Carlson MD; Gatzoylis KA; Henthorn RW; Waldo AL J Am Coll Cardiol; 1993 Oct; 22(4):1117-22. PubMed ID: 8409050 [TBL] [Abstract][Full Text] [Related]
5. Non-contact mapping to guide catheter ablation of untolerated ventricular tachycardia. Della Bella P; Pappalardo A; Riva S; Tondo C; Fassini G; Trevisi N Eur Heart J; 2002 May; 23(9):742-52. PubMed ID: 11978001 [TBL] [Abstract][Full Text] [Related]
6. [Anti-tachycardia stimulation in supraventricular and ventricular tachycardia with and without cardioverter/defibrillator]. Klein H Herz; 1991 Jun; 16(3):182-98. PubMed ID: 1889793 [TBL] [Abstract][Full Text] [Related]
7. [Factors predicting the response to an antiarrhythmic during an electrophysiologic study for ventricular tachycardia]. Brembilla-Perrot B; Terrier de la Chaise A; Skeik L; Cherrier F; Pernot C Arch Mal Coeur Vaiss; 1987 Sep; 80(10):1497-503. PubMed ID: 3125809 [TBL] [Abstract][Full Text] [Related]
8. Influence of tachycardia cycle length and antiarrhythmic drugs on pacing termination and acceleration of ventricular tachycardia. Naccarelli GV; Zipes DP; Rahilly GT; Heger JJ; Prystowsky EN Am Heart J; 1983 Jan; 105(1):1-5. PubMed ID: 6849222 [TBL] [Abstract][Full Text] [Related]
9. Does mexiletine have a preferential action (versus healthy myocardium) on the reentrant circuit of ventricular tachycardia? Abe A; Aizawa Y; Ma M Heart Vessels; 1997; Suppl 12():235-9. PubMed ID: 9476592 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of malignant ventricular arrhythmia guided by electrophysiologic study]. Brandão L; Carpinteiro L; Sousa J; Vagueiro MC Acta Med Port; 1998 Jan; 11(1):9-16. PubMed ID: 9580363 [TBL] [Abstract][Full Text] [Related]
11. Discrimination between monomorphic and polymorphic ventricular tachycardia using cycle length variability measured by wavelet transform analysis. Sierra G; Gómez MJ; Le Guyader P; Trelles F; Cardinal R; Savard P; Nadeau R J Electrocardiol; 1998 Jul; 31(3):245-55. PubMed ID: 9682901 [TBL] [Abstract][Full Text] [Related]
12. [Calcium antagonists in treatment of ventricular tachycardia]. Melichercik J; Schöls W; Beyer T; Schweizer M; Brachmann J; Kübler W Z Kardiol; 1996 May; 85(5):319-25. PubMed ID: 8711944 [TBL] [Abstract][Full Text] [Related]
13. [Which patient with sustained ventricular tachycardia is suited for long-term therapy with anti-arrhythmia drugs?]. Steinbeck G Z Gesamte Inn Med; 1992 May; 47(5):195-201. PubMed ID: 1615729 [TBL] [Abstract][Full Text] [Related]